Immune cells express an array of inhibitory checkpoint receptors that are upregulated upon activation and limit tissue damage associated with excessive response to pathogens or allergens. Mouse leukocyte immunoglobulin like receptor B4 (LILRB4), also known as glycoprotein 49B (gp49B), is an inhibitory checkpoint receptor constitutively expressed in myeloid cells and upregulated in B cells, T cells, and NK cells upon activation. Here, we report that expression of LILRB4, which binds Zika virus (ZIKV), was increased in microglia and myeloid cells infiltrating the brains of neonatal mice with ZIKV-associated meningoencephalitis. Importantly, while C57BL/6 mice developed transient neurological symptoms but survived infection, mice lacking LILRB4/gp49B (LILRB4 KO) exhibited more severe signs of neurological disease and succumbed to disease. Their brains showed increased cellular infiltration but reduced control of viral burden. The reduced viral clearance was associated with altered NK cell function in the absence of LILRB4/gp49B. In naive animals, this manifested as reduced granzyme B responses to stimulation, but in ZIKV-infected animals, NK cells showed phenotypic changes that suggested altered maturation, diminished glucose consumption, reduced IFN-γ and granzyme B production, and impaired cytotoxicity. Together, our data reveal LILRB4/gp49B as an important regulator of NK cell function during viral infections.
Ha-Na Lee, Mohanraj Manangeeswaran, Aaron P. Lewkowicz, Kaliroi Engel, Monica Chowdhury, Mamatha Garige, Michael A. Eckhaus, Carole Sourbier, Derek D.C. Ireland, Daniela Verthelyi
Title and authors | Publication | Year |
---|---|---|
Exploring Mosquito Excreta as an Alternative Sample Type for Improving Arbovirus Surveillance in Australia
Malcolm TR, Klein MJ, Petkovic K, Smith I, Blasdell KR |
Pathogens | 2025 |
LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets.
Xiang Z, Yin X, Wei L, Peng M, Zhu Q, Lu X, Guo J, Zhang J, Li X, Zou Y, Xiang Z, Yin X, Wei L, Peng M, Zhu Q, Lu X, Guo J, Zhang J, Li X, Zou Y |
Biomolecules | 2024 |
Innate lymphoid cells in neuroinflammation
Kveštak D, Mihalić A, Jonjić S, Brizić I |
Frontiers in cellular neuroscience | 2024 |
Tissue-specific features of innate lymphoid cells in antiviral defense.
Piersma SJ, Piersma SJ |
Cellular & molecular immunology | 2024 |
Loss of Mitochondrial Tusc2/Fus1 Triggers a Brain Pro-Inflammatory Microenvironment and Early Spatial Memory Impairment
Farris T, González-Ochoa S, Mohammed M, Rajakaruna H, Tonello J, Kanagasabai T, Korolkova O, Shimamoto A, Ivanova A, Shanker A |
International journal of molecular sciences | 2024 |
The post‐stroke young adult brain has limited capacity to re‐express the gene expression patterns seen during early postnatal brain development
Ruscu M, Capitanescu B, Rupek P, Dandekar T, Radu E, Hermann DM, Popa\u2010Wagner A |
Brain Pathology | 2024 |
Microglia LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8+ T cell recruitment
Ma Y, Zheng K, Zhao C, Chen J, Chen L, Zhang Y, Chen T, Yao X, Cai Y, Wu J |
Journal of Neuroinflammation | 2024 |
Effects of Mycobacterium vaccae NCTC 11659 and Lipopolysaccharide Challenge on Polarization of Murine BV-2 Microglial Cells
Desmond LW, Holbrook EM, Wright CT, Zambrano CA, Stamper CE, Bohr AD, Frank MG, Podell BK, Moreno JA, MacDonald AS, Reber SO, Hernández-Pando R, Lowry CA |
International journal of molecular sciences | 2023 |
Peptide drugs: a new direction in cancer immunotherapy
Sui X, Niu X, Zhou X, Gao Y |
Cancer biology & medicine | 2023 |